Exact Mass: 387.0099

Exact Mass Matches: 387.0099

Found 18 metabolites which its exact mass value is equals to given mass value 387.0099, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

benzylhydrochlorothiazide

2H-1,2,4-Benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-3-(phenylmethyl)-, 1,1-dioxide

C14H14ClN3O4S2 (387.0114)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic Same as: D01246

   

3',4'-Dichlorobenzamil

3,5-diamino-6-chloro-N-{N-[(3,4-dichlorophenyl)methyl]carbamimidoyl}pyrazine-2-carboxamide

C13H12Cl3N7O (387.0169)


   

MMV687699

MMV687699

C16H10Cl2F3N3O (387.0153)


   

glutathioselenol

glutathioselenol

C10H17N3O6SSe (387.0003)


A glutathione derivative that is glutathione in which the hydrogen attached to the sulfur is replaced by a selenol group.

   

MMV687699

MMV687699

C16H10N3OCl2F3 (387.0153)


   

GSSeH

glutathioselenol

C10H17N3O6SSe (387.0003)


   

6-BROMO-2-(2,4-DIMETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(2,4-DIMETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H14BrNO4 (387.0106)


   

3-BOC-2-(4-BROMO-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID

3-BOC-2-(4-BROMO-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID

C15H18BrNO4S (387.014)


   

3-Bromo-N,N-dipropyl-5-(trifluoromethyl)benzenesulfonamide

3-Bromo-N,N-dipropyl-5-(trifluoromethyl)benzenesulfonamide

C13H17BrF3NO2S (387.0115)


   

Benzenesulfonylchloride, 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]-

Benzenesulfonylchloride, 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]-

C16H15Cl2NO4S (387.0099)


   

O-[3-chloro-4-(diethylsulfamoyl)phenyl] O,O-dimethyl phosphorothioate

O-[3-chloro-4-(diethylsulfamoyl)phenyl] O,O-dimethyl phosphorothioate

C12H19ClNO5PS2 (387.0131)


   

Bromotris(dimethylamino)phosphonium hexafluorophosphate

Bromotris(dimethylamino)phosphonium hexafluorophosphate

C6H18BrF6N3P2 (387.0063)


   

3-Bromo-N-hexyl-5-(trifluoromethyl)benzenesulfonamide

3-Bromo-N-hexyl-5-(trifluoromethyl)benzenesulfonamide

C13H17BrF3NO2S (387.0115)


   

Tcmdc-142530

Tcmdc-142530

C16H10Cl2F3N3O (387.0153)


   

3,5-diamino-N-[amino-[(2,4-dichlorophenyl)methylimino]methyl]-6-chloro-2-pyrazinecarboxamide

3,5-diamino-N-[amino-[(2,4-dichlorophenyl)methylimino]methyl]-6-chloro-2-pyrazinecarboxamide

C13H12Cl3N7O (387.0169)


   

2-[(2,4-dichlorophenoxy)acetyl]-N-(4-fluorophenyl)hydrazinecarbothioamide

2-[(2,4-dichlorophenoxy)acetyl]-N-(4-fluorophenyl)hydrazinecarbothioamide

C15H12Cl2FN3O2S (387.0011)


   

3,4-Dichlorobenzamil

3,4-Dichlorobenzamil

C13H12Cl3N7O (387.0169)


   

ERK5-IN-2

ERK5-IN-2

C17H11BrFN3O2 (387.0019)


ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively. ERK5-IN-2 does not interact with the BRD4 bromodomain. ERK5-IN-2 suppresses both tumor xenograft growth and basic fibroblast growth factor (bFGF) driven Matrigel plug angiogenesis[1].